Gaviscon (Alumina & Magnesium Trisilicate)
Superpotent Drug: high out-of-specification result for magnesium.
Class III means the product is unlikely to cause harm but violates FDA labeling or manufacturing rules. These are the recalls you rarely hear about; pharmacies usually just swap the affected lot.
1,716 recalls, newest first.
Superpotent Drug: high out-of-specification result for magnesium.
Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for Day-Night Cold and Flu whereas the batch contains Day-Night Cough Liquid.
Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.
Failed Moisture Limits: Product tested out-of-specification for moisture content.
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules
Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent
Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.
Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities
Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
Superpotent Drug: above specification for the assay.
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.
CGMP Deviations
Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.
Presence of Foreign Substance: human hair melded into tablet.
Subpotent Drug; Clavulanic Acid
Product is being recalled due to low pH value.
Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.
Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.
Subpotent: This product is being recalled due to low out of specification assay results at the 9 month time point.
Superpotent Drug
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Failed Stability Specifications
Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).